Teva files EU court challenge over antitrust fine for MS-drug abuse
Teva Pharmaceuticals has taken its fight against a 462.6 million euro antitrust fine to EU judges, disputing a decision in October that said the company had misused the patent system and spread...To view the full article, register now.
Already a subscriber? Click here to view full article